Newsfiscal.ai
Decoy Therapeutics Provides Third Quarter 2026 Business Update
· Published
Article summary
Decoy Therapeutics reported progress on its antiviral pipeline, highlighting an optimized pan-coronavirus lead candidate and a cash position of $8.1 million.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…